These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38055626)

  • 1. Statin use moderates APOE's and CRP's associations with dementia and is associated with lesser dementia severity in ε4 carriers.
    Royall DR; Palmer RF;
    Alzheimers Dement; 2024 Mar; 20(3):1627-1636. PubMed ID: 38055626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
    Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
    Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Few serum proteins mediate APOE's association with dementia.
    Royall DR; Al-Rubaye S; Bishnoi R; Palmer RF
    PLoS One; 2017; 12(3):e0172268. PubMed ID: 28291794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inverse association between the apolipoprotein E ε4 allele and C-reactive protein levels is stronger in persons with obesity and diabetes.
    Giil LM; Hanseth S; Bojovic O; Nordrehaug JE; Ueland PM; Meyer K; Tell GS
    Scand J Immunol; 2024 Jan; 99(1):e13323. PubMed ID: 37801334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin users without an APOE-epsilon4 allele have increased insulin resistance.
    VanFossen BT; Watson GS; Baker LD; Rhoads KW; Cholerton BA; Reger MA; Plymate SR; Schellenberg G; Craft S
    J Alzheimers Dis; 2010; 19(4):1149-53. PubMed ID: 20308781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin Initiation and Risk of Incident Alzheimer Disease and Cognitive Decline in Genetically Susceptible Older Adults.
    Rajan KB; Mcaninch EA; Wilson RS; Dhana A; Evans-Lacko S; Evans DA
    Neurology; 2024 Apr; 102(7):e209168. PubMed ID: 38447103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study.
    Eiriksdottir G; Aspelund T; Bjarnadottir K; Olafsdottir E; Gudnason V; Launer LJ; Harris TB
    Atherosclerosis; 2006 May; 186(1):222-4. PubMed ID: 16445917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers.
    Hackenhaar FS; Josefsson M; Adolfsson AN; Landfors M; Kauppi K; Hultdin M; Adolfsson R; Degerman S; Pudas S
    Alzheimers Res Ther; 2021 Jul; 13(1):130. PubMed ID: 34266503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab.
    Korthauer LE; Giugliano RP; Guo J; Sabatine MS; Sever P; Keech A; Atar D; Kurtz C; Ruff CT; Mach F; Ott BR
    PLoS One; 2022; 17(4):e0266615. PubMed ID: 35404972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of increasing levels of blood C-reactive protein on the inflammatory loci SPI1 and CD33 in Alzheimer's disease.
    Huang J; Tao Q; Ang TFA; Farrell J; Zhu C; Wang Y; Stein TD; Lunetta KL; Massaro J; Mez J; Au R; Farrer LA; Qiu WQ; Zhang X;
    Transl Psychiatry; 2022 Dec; 12(1):523. PubMed ID: 36550123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Low-Dose Statins and Apolipoprotein E Genotype on Cerebral Small Vessel Disease in Older Hypertensive Patients: A Subgroup Analysis of a Randomized Clinical Trial.
    Ji T; Zhao Y; Wang J; Cui Y; Duan D; Chai Q; Zhang H; Liu Z
    J Am Med Dir Assoc; 2018 Nov; 19(11):995-1002.e4. PubMed ID: 30006015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
    Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
    PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of C-Reactive Protein on Cognition and Alzheimer Disease Biomarkers in Homozygous
    Tao Q; Alvin Ang TF; Akhter-Khan SC; Itchapurapu IS; Killiany R; Zhang X; Budson AE; Turk KW; Goldstein L; Mez J; Alosco ML; Qiu WQ;
    Neurology; 2021 Sep; 97(12):e1243-e1252. PubMed ID: 34266923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function.
    Xu Y; Sun Z; Jonaitis E; Deming Y; Lu Q; Johnson SC; Engelman CD
    Alzheimers Dement; 2024 Feb; 20(2):1063-1075. PubMed ID: 37858606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.
    Dufouil C; Richard F; Fiévet N; Dartigues JF; Ritchie K; Tzourio C; Amouyel P; Alpérovitch A
    Neurology; 2005 May; 64(9):1531-8. PubMed ID: 15883313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease.
    Kennedy RE; Cutter GR; Schneider LS
    Alzheimers Dement; 2014 May; 10(3):349-59. PubMed ID: 23712001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric symptoms and ApoE genotype in older adults without dementia: a cross-sectional study.
    Stella F; Pais MV; Loureiro JC; Cordeiro AMT; Talib LL; Forlenza OV
    Psychogeriatrics; 2024 Mar; 24(2):382-390. PubMed ID: 38303161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE ε4, Alzheimer's disease neuropathology and sleep disturbance, in individuals with and without dementia.
    Blackman J; Love S; Sinclair L; Cain R; Coulthard E
    Alzheimers Res Ther; 2022 Mar; 14(1):47. PubMed ID: 35354468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.